My Profile e-Learning Center my.ASTHO Contact Us

Filter Results

Clear All Filters

Topic

Product Type

Location

Contributor

Published Date

Displaying 2 results for

GO
Search Filters: New York cancel Illinois cancel Social and Behavioral Health cancel Maryland cancel Indiana cancel Population Health and Prevention cancel

2022 Legislative Session Update: Part Two

Blog,
Health Policy Update,
Policy,
State Health Policy,
Population Health and Prevention,
Social and Behavioral Health,
STIs,
HIV,
Tobacco Control,
Mental Health,
Environmental Health,
Food and Water Safety,
PFAS,
Health Equity,
Rural Health,
Infectious Disease,
West Virginia,
Wyoming,
New Jersey,
California,
Washington, D.C.,
New York,
Colorado,
Connecticut,
Hawaii,
Illinois,
Indiana,
Rhode Island,
Minnesota,
Washington,
Maryland,
Parker Beene,
Maggie Davis,
Beth Giambrone

The ASTHO State Health Policy team provides brief updates on 5 of the ten state health policy issues to watch in 2022: mental and behavioral health, rural health, e-cigarettes and flavored tobacco products, HIV and PFAS.

How the Emergence of Xylazine Impacts Overdose Prevention Policy

Policy,
State Health Policy,
Population Health and Prevention,
Social and Behavioral Health,
Substance Misuse,
Overdose Prevention,
Alaska,
Colorado,
Guam,
Maine,
Maryland,
Nebraska,
New York,
Northern Mariana Islands,
Pennsylvania,
South Carolina,
Vermont,
Illinois,
New Hampshire,
Delaware,
New Jersey,
Florida,
Massachusetts,
Utah,
Michigan,
Rhode Island,
Oklahoma,
West Virginia,
Indiana,
Puerto Rico,
JoAnne McClure,
Victoria Pless,
Blog,
Health Policy Update,
Ohio

How the Emergence of Xylazine Impacts Overdose Prevention Policy overdose prevention policy, overdose crisis, fatal overdoses, emergence of xylazine, illicit drug supply, toxicological testing, withdrawal symptoms, xylazine test strips, ...